Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xencor

7.95
-0.0300-0.38%
Volume:595.09K
Turnover:4.72M
Market Cap:565.81M
PE:-2.61
High:8.17
Open:8.01
Low:7.68
Close:7.98
Loading ...

Xencor initiated with an Outperform at William Blair

TIPRANKS
·
21 Apr

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

Xencor Appoints Todd Simpson To Board Of Directors

Reuters
·
14 Mar

Xencor Appoints Todd Simpson to Board of Directors

Business Wire
·
14 Mar

BEAM Down Despite Positive Initial Data From Genetic Disorder Study

Zacks
·
12 Mar

PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy

Zacks
·
07 Mar

Barclays Reaffirms Their Sell Rating on Xencor (XNCR)

TIPRANKS
·
02 Mar

Xencor Is Maintained at Overweight by Wells Fargo

Dow Jones
·
01 Mar

RBC Capital Adjusts Xencor Price Target to $32 From $34, Maintains Outperform - Speculative Risk Rating

MT Newswires Live
·
28 Feb

Xencor price target lowered to $31 from $38 at Wedbush

TIPRANKS
·
28 Feb

Wedbush Cuts Price Target on Xencor to $31 From $38, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Xencor Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Feb

Strategic Shift and Promising Pipeline: Xencor’s Growth Potential and Investment Opportunity

TIPRANKS
·
28 Feb

Xencor Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Xencor's Q4 Net Loss Widens, Revenue Rises

MT Newswires Live
·
27 Feb

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
27 Feb

Xencor reports Q4 EPS ( 62c), consensus (78c)

TIPRANKS
·
27 Feb

Xencor: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Xencor Q4 EPS $(0.62) Beats $(0.78) Estimate, Sales $52.79M Beat $19.48M Estimate

Benzinga
·
27 Feb

Earnings Flash (XNCR) Xencor Posts Q4 Net Loss $0.62 a Share, vs. FactSet Est of $0.78 Loss

MT Newswires Live
·
27 Feb